Precision oncology for biliary tract tumors: it's written in blood!

Ann Oncol. 2022 Dec;33(12):1209-1211. doi: 10.1016/j.annonc.2022.09.157. Epub 2022 Sep 28.

Authors

M A Gouda¹, V Subbiah²

Affiliations

¹ Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston.
² Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: vsubbiah@mdanderson.org.

PMID: 36182024
DOI: 10.1016/j.annonc.2022.09.157

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biliary Tract Neoplasms* / therapy
Humans
Medical Oncology
Precision Medicine*

Grants and funding